Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Rifampicin-resistant tuberculosis among known HIV-infected patients in Oyo State, Nigeria.

Adetunji SO, Donbraye E, Ekong MJ, Adetunji BI.

J Immunoassay Immunochem. 2019;40(3):289-299. doi: 10.1080/15321819.2019.1583579. Epub 2019 Mar 5.

PMID:
30835618
2.

Knowledge, attitude and practice of standard precautions of infection control by hospital workers in two tertiary hospitals in Nigeria.

Ogoina D, Pondei K, Adetunji B, Chima G, Isichei C, Gidado S.

J Infect Prev. 2015 Jan;16(1):16-22. doi: 10.1177/1757177414558957. Epub 2015 Jan 5.

3.

Prevalence of hepatitis B vaccination among health care workers in Nigeria in 2011-12.

Ogoina D, Pondei K, Adetunji B, Chima G, Isichei C, Gidado S.

Int J Occup Environ Med. 2014 Jan;5(1):51-6.

4.
5.

Lithium in mood disorders: a one-sided re-appraisal.

Adetunji B, Adetunji O, Newton A.

Br J Psychiatry. 2008 May;192(5):395; author reply 395. doi: 10.1192/bjp.192.5.395a. No abstract available.

PMID:
18450673
6.

"Bipolar family": useful mnemonic to differentiate bipolar from unipolar depression.

Adetunji B, Mathews M, Basil B, Oyemade A.

Prim Care Companion J Clin Psychiatry. 2007;9(2):152-3. No abstract available.

7.

Re: Authorship in psychiatry: a perspective.

Adetunji B.

J Am Acad Psychiatry Law. 2007;35(2):276. No abstract available.

PMID:
17592173
8.

Prescribing for buprenorphine in the treatment of opioid addiction.

Oyemade A, Adetunji B, Basil B, Mathews M.

Psychiatry (Edgmont). 2007 Mar;4(3):16. No abstract available.

9.

Mirtazapine-induced nightmares.

Mathews M, Basil B, Evcimen H, Adetunji B, Joseph S.

Prim Care Companion J Clin Psychiatry. 2006;8(5):311. No abstract available.

10.

Mirtazapine-associated dose-dependent and asymptomatic elevation of hepatic enzymes.

Adetunji B, Basil B, Mathews M, Osinowo T.

Ann Pharmacother. 2007 Feb;41(2):359. Epub 2007 Jan 23. No abstract available.

PMID:
17244643
11.

Tardive seizure: a case report.

Williams A, Adetunji B, Odulate A.

J ECT. 2006 Dec;22(4):271.

PMID:
17143160
12.

Should the Physician's Desk Reference contraindicate the use of chlorpromazine-fluoxetine combination? A case report.

Adetunji B, Basil B, Mathews M, Osinowo T.

J Clin Psychopharmacol. 2006 Aug;26(4):438. No abstract available.

PMID:
16855470
13.

Methodological issues in a study of long-term maintenance therapy with quetiapine versus haloperidol decanoate.

Adetunji B, Basil B, Mathews M, Williams A, Osinowo T.

J Clin Psychiatry. 2006 Mar;67(3):497; author reply 497-8. No abstract available.

PMID:
16649843
14.

Trial of risperidone in India--concerns.

Basil B, Adetunji B, Mathews M, Budur K.

Br J Psychiatry. 2006 May;188:489-90; author reply 490-1; discussion 491-2. No abstract available.

PMID:
16648540
15.

Assessment and treatment of Iraqi prisoners and civilians.

Mathews M, Basil B, Adetunji B.

Psychiatr Serv. 2006 Apr;57(4):580; author reply 581. No abstract available.

PMID:
16603767
16.

Pathological lying.

Adetunji B, Basil B, Budur K, Oladinni O.

J Am Acad Psychiatry Law. 2006;34(1):131-2; author reply 132-3. No abstract available.

PMID:
16585256
17.

The CATIE study.

Basil B, Mathews M, Adetunji B, Budur K.

Am J Psychiatry. 2006 Mar;163(3):555; author reply 555-6. No abstract available.

PMID:
16513895
18.

Risperidone for the core symptom domains of autism.

Adetunji B, Mathews M, Osinowo T, Williams A.

Am J Psychiatry. 2006 Mar;163(3):551; author reply 551-2. No abstract available.

PMID:
16513891
19.

Is there evidence for effectiveness of acamprosate in maintaining abstinence in alcohol dependent patients?

Basil B, Thomas M, Chakrabarti I, George V, Mathews M, Adetunji B.

Psychiatry (Edgmont). 2005 Dec;2(12):49-52. No abstract available.

20.

India plans to audit clinical trials.

Basil B, Mathews M, Mahmud J, Adetunji B, Budur K.

BMJ. 2005 Nov 19;331(7526):1204-5. No abstract available.

21.

Is there evidence for effectiveness of transcranial magnetic stimulation in the treatment of psychiatric disorders?

Basil B, Mahmud J, Mathews M, Rodriguez C, Adetunji B.

Psychiatry (Edgmont). 2005 Nov;2(11):64-9.

22.

Olanzapine and olanzapine-fluoxetine combination treatment and bipolar I depression.

Williams AB, Adetunji BA.

Arch Gen Psychiatry. 2005 Sep;62(9):1052; author reply 1052. No abstract available.

PMID:
16143737
23.

Pants, elevators, and brand names.

Adetunji B.

Psychiatry (Edgmont). 2005 Sep;2(9):26-9. No abstract available.

24.

Dangerous people with severe personality disorders.

Adetunji B, Williams A, Oladini O.

Psychiatr Serv. 2005 Jul;56(7):872-3. No abstract available.

PMID:
16020825
25.

Non-stimulant treatment for attention deficit hyperactivity disorder.

Budur K, Mathews M, Adetunji B, Mathews M, Mahmud J.

Psychiatry (Edgmont). 2005 Jul;2(7):44-8. No abstract available.

26.

Child psychopharmacology, effect sizes, and the big bang.

Mathews M, Adetunji B, Mathews J, Basil B, George V, Mathews M, Budur K, Abraham S.

Am J Psychiatry. 2005 Apr;162(4):818; author reply 818-9. No abstract available.

PMID:
15800177
27.

Use of antipsychotics in the treatment of post-traumatic stress disorder.

Adetunji B, Mathews M, Williams A, Budur K, Mathews M, Mahmud J, Osinowo T.

Psychiatry (Edgmont). 2005 Apr;2(4):43-7.

28.

Antipsychotic-induced movement disorders: evaluation and treatment.

Mathews M, Gratz S, Adetunji B, George V, Mathews M, Basil B.

Psychiatry (Edgmont). 2005 Mar;2(3):36-41. No abstract available.

29.

Long-acting risperidone in the treatment of schizophrenia: an evidence-based approach.

Mathews M, Adetunji B, Mahmud J, George V, Thomas M, Joseph S.

Psychiatry (Edgmont). 2005 Feb;2(2):36-9. No abstract available.

30.

Evidence-based addiction medicine: the use of lofexidine for opioid detoxification.

Adetunji B, Mathews M, Williams A, Rufai O.

Psychiatry (Edgmont). 2004 Nov;1(3):32-5.

31.

Training in transcultural psychiatry to reduce racial and ethnic disparities.

Adetunji BA, Osinowo TO, Williams AB.

Psychiatr Serv. 2004 May;55(5):588; author reply 588-9. No abstract available.

PMID:
15128974

Supplemental Content

Loading ...
Support Center